NCT06822114View on ClinicalTrials.gov

Substance Balance Trial of Methoxyethyl Etomidate Hydrochloride

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

July 17, 2023

Primary Completion Date

July 31, 2023

Study Completion Date

July 31, 2023

Conditions
Pharmacokinetics
Interventions
DRUG

Methoxyethyl Etomidate Hydrochloride

The dose is 50 μCi/48 mg，in the fasting state, a single intravenous injection was given slowly

Trial Locations (1)

215000

The First Affiliated Hospital of Soochow University, Suzhou

Sponsors
All Listed Sponsors
lead

Ahon Pharmaceutical Co., Ltd.

OTHER